Evaluation of Immunopharmacological Efficacy of Live Leishmania donovani Overexpressing Ld_ζ1domain for Protection Against Experimental Human Visceral Leishmaniasis
Ruby Bansal, Sadat Shafi, Prachi Garg, Aakriti Srivastava, Swati Garg, Neha Jha, Jhalak Singhal, Gajala Deethamvali Ghouse Peer, Ramendra Pati Pandey, Subhajit Basu, Shailja Singh
This study evaluates the immunopharmacological efficacy of Leishmania donovani overexpressing Ld_ζ1domain as a vaccine candidate against visceral leishmaniasis, showing reduced parasite burden and enhanced immune response.
International Immunopharmacology · Feb 20, 2025Peer-reviewedPathology